DK117587B - Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse. - Google Patents

Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.

Info

Publication number
DK117587B
DK117587B DK282167AA DK282167A DK117587B DK 117587 B DK117587 B DK 117587B DK 282167A A DK282167A A DK 282167AA DK 282167 A DK282167 A DK 282167A DK 117587 B DK117587 B DK 117587B
Authority
DK
Denmark
Prior art keywords
oxytetracycline
parenteral
oral
preparation
aqueous solutions
Prior art date
Application number
DK282167AA
Other languages
Danish (da)
English (en)
Inventor
H Weber
A Molenaar
Original Assignee
Koninklijke Gist Spiritus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Gist Spiritus filed Critical Koninklijke Gist Spiritus
Publication of DK117587B publication Critical patent/DK117587B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK282167AA 1966-05-31 1967-05-30 Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse. DK117587B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (ja) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
DK117587B true DK117587B (da) 1970-05-11

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK282167AA DK117587B (da) 1966-05-31 1967-05-30 Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.

Country Status (22)

Country Link
US (1) US3557280A (ja)
JP (1) JPS5010373B1 (ja)
AT (1) AT272522B (ja)
BE (1) BE699091A (ja)
CH (1) CH490087A (ja)
CS (1) CS151454B2 (ja)
DE (1) DE1617576C3 (ja)
DK (1) DK117587B (ja)
ES (1) ES340956A1 (ja)
FI (1) FI43622B (ja)
FR (1) FR5953M (ja)
GB (1) GB1131007A (ja)
GR (1) GR33861B (ja)
IL (1) IL28009A (ja)
IT (1) IT1140250B (ja)
LU (1) LU53788A1 (ja)
MY (1) MY7100015A (ja)
NL (1) NL6607516A (ja)
NO (1) NO126298B (ja)
SE (1) SE354417B (ja)
SU (1) SU510986A3 (ja)
YU (1) YU31326B (ja)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (ja) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
HUP0202798A3 (en) 1999-09-14 2003-11-28 Trustees Of Tufts College Medf Methods of preparing substituted tetracyclines with transition metal-based reactions
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
AU3105801A (en) * 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
US6818634B2 (en) * 2000-03-31 2004-11-16 Paratek Pharmaceuticals, Inc. 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
EP1286954B1 (en) 2000-05-15 2004-04-14 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
CN102336679A (zh) 2000-07-07 2012-02-01 塔夫茨大学信托人 7-取代的四环素化合物
US6624168B2 (en) 2000-07-07 2003-09-23 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
CZ2003332A3 (cs) 2000-07-07 2003-05-14 Trustees Of Tufts College 13-Substituované methacyklinové sloučeniny
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
CA2415178C (en) 2000-07-07 2010-05-25 Trustees Of Tufts College 9-substituted minocycline compounds
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP2298732A1 (en) 2001-03-13 2011-03-23 Paratek Pharmaceuticals, Inc. 7,9-Substituted tetracycline compounds
WO2002072022A2 (en) * 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
EP1381372A2 (en) 2001-03-14 2004-01-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2002085303A2 (en) 2001-04-24 2002-10-31 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
JP2005514410A (ja) 2002-01-08 2005-05-19 パラテック ファーマシューティカルズ インコーポレイテッド ４−デジメチルアミノテトラサイクリン化合物
CA2478335C (en) 2002-03-08 2011-05-10 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
AU2003218243B2 (en) 2002-03-21 2010-04-01 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
KR101089429B1 (ko) 2002-07-12 2011-12-07 파라테크 파마슈티컬스, 인크. 3, 10, 및 12ａ 치환된 테트라시클린 화합물
JP2006503898A (ja) 2002-10-24 2006-02-02 パラテック ファーマシューティカルズ， インク． マラリア治療のための置換テトラサイクリン化合物
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
EA200600221A1 (ru) 2003-07-09 2006-06-30 Пэрэтек Фамэсьютикэлс, Инк. Замещённые соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
WO2005070878A1 (en) * 2004-01-15 2005-08-04 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2033950A1 (en) 2004-10-25 2009-03-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2301916A3 (en) 2004-10-25 2011-09-28 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
WO2006084265A1 (en) * 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDS
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
JP2009502809A (ja) * 2005-07-21 2009-01-29 パラテック ファーマシューティカルズ インコーポレイテッド １０−置換テトラサイクリンおよびその使用方法
JP2009508951A (ja) * 2005-09-19 2009-03-05 アルベマール・コーポレーシヨン カリウムイブプロフェンの極めて濃厚な注入可能な水溶液、その製造法および使用
EP1991236A2 (en) 2006-01-24 2008-11-19 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
CA2649221A1 (en) * 2006-04-17 2007-10-25 Evgeny Tsiperman Isolation of tetracycline derivatives
EP2857386B1 (en) * 2006-04-24 2017-02-22 Teva Pharmaceutical Industries Ltd Tigecycline crystalline forms and processes for preparation thereof
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
WO2007133798A2 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
EP3812372A3 (en) 2006-12-21 2021-06-30 Paratek Pharmaceuticals, Inc. 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases
WO2008079363A2 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
JP2010523684A (ja) * 2007-04-12 2010-07-15 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物を用いる、脊髄筋委縮症を治療するための方法
JP2010525069A (ja) * 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
DK2176216T3 (da) 2007-07-06 2012-07-30 Paratek Pharm Innc Fremgangsmåder til syntetisering af 9-substitueret minocyclin
KR20100126469A (ko) 2008-03-05 2010-12-01 파라테크 파마슈티컬스, 인크. 미노사이클린 화합물 및 이들의 사용 방법
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
AU2009236631A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202332671A (zh) 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
EP2309988B1 (en) * 2008-07-21 2015-11-25 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CA2737470A1 (en) * 2008-09-19 2010-03-25 Paratek Pharmaceuticals, Inc. Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
CA2758322C (en) 2009-04-10 2019-04-02 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
EP2707003B1 (en) 2011-05-12 2019-05-01 Paratek Pharmaceuticals, Inc. Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
US10383884B2 (en) 2016-11-01 2019-08-20 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
WO2019016609A1 (en) 2017-07-21 2019-01-24 Allergan Pharmaceuticals International Limited TREATMENT OF NON-INFLAMMATORY LESIONS

Also Published As

Publication number Publication date
FR5953M (ja) 1968-04-16
IL28009A (en) 1970-08-19
US3557280A (en) 1971-01-19
GB1131007A (en) 1968-10-16
DE1617576C3 (de) 1980-12-11
DE1617576A1 (de) 1972-04-27
MY7100015A (en) 1971-12-31
DE1617576B2 (de) 1980-04-10
ES340956A1 (es) 1968-06-16
SU510986A3 (ru) 1976-04-15
FI43622B (ja) 1971-02-01
NL6607516A (ja) 1967-12-01
NO126298B (ja) 1973-01-22
LU53788A1 (ja) 1967-07-31
YU31326B (en) 1973-04-30
AT272522B (de) 1969-07-10
BE699091A (ja) 1967-11-27
GR33861B (el) 1968-02-09
IT1140250B (it) 1986-09-24
SE354417B (ja) 1973-03-12
CH490087A (de) 1970-05-15
JPS5010373B1 (ja) 1975-04-21
CS151454B2 (ja) 1973-10-19

Similar Documents

Publication Publication Date Title
DK117587B (da) Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
DK127168B (da) Fremgangsmåde til fremstilling af klare, stabile vandige opløsninger af doxycyclin, som er egnede til parenteral, oral og topisk brug.
FI52078C (fi) Menetelmä N-alkyyli-1,4-dihydro-pyridiinien valmistamiseksi.
DK138974B (da) Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DK115569B (da) Fremgangsmåde til fremstilling af ascorbinsyreholdige præparater.
DK129390B (da) Fremgangsmåde til fremstilling af til parenteral indgift egnede anæstetisk virksomme opløsninger af et steroid.
DK131905B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazinderivater og syreadditionssalte deraf.
FI49301C (fi) Menetelmä uusien substituoitujen aminopyridiinien valmistamiseksi, joi lla on tulehduksenvastainen ja kipua lieventävä vaikutus.
DK121804B (da) Analogifremgangsmåde til fremstilling af 4-hydroxycumarinderivater.
DK111568B (da) Fremgangsmåde til fremstilling af N-alkyl-3,1-benzoxazin-2-oner.
DK123351B (da) Analogifremgangsmåde til fremstilling af trifluormethyl-derivater af phenylaminopropan.
DK117832B (da) Fremgangsmåde til fremstilling af ɛ-caprolactam og ω-decalactam.
DK115178B (da) Analogifremgangsmåde til fremstilling af acylderivater af proscillaridin A.
DK123299B (da) Analogifremgangsmåde til fremstilling af pyridazonderivater.
DK117961B (da) Analogifremgangsmåde til fremstilling af guanidinderivater.
DK130796B (da) Fremgangsmåde til fremstilling af et stabilt cellefrit viruspræparat.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK118261B (da) Fremgangsmåde til fremstilling af til parenteral indgift egnede stabile opløsninger af benzodiazepinderivater.
DK122761B (da) Analogifremgangsmåde til fremstilling af arylsulfonylurinstofderivater.
DK126105B (da) Fremgangsmåde til fremstilling af meget ren 2,6-xylenol.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK127418B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener.
DK117703B (da) Analogifremgangsmåde til fremstilling af anticoccidielt aktive quinolinderivater.
DK124401B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer.
DK114270B (da) Fremgangsmåde til fremstilling af benzazolderivater.